ArticleBMC cancer2020

Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes.

Youzhi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.